eStrat

Based in the US, eStrat provides pharmaceutical service solutions, emphasizing Co-Pay Assistance Programs and specialized returns management services to enhance efficiency in the healthcare sector. eStrat is a pharmaceutical service provider headquartered in Raleigh, US, focusing on co-pay assistance and returns management. Founded with a vision to streamline pharmaceutical operations, it was acquired by Apollo Care, a portfolio company of Flexpoint Ford, in January 2026 for undisclosed financial terms. The founder's past ventures are not documented in available data.

eStrat specializes in providing pharmaceutical service solutions, focusing primarily on Co-Pay Assistance Programs, Free Trial Offers, Closed Network Pharmacies, and Returns Management Services. Their Co-Pay Assistance Programs utilize modern methodologies to address pharmacy price control while mitigating potential fraudulent activities within pharmacy settings. The Free Trial Offers are designed to be pharmacy adjudicated, allowing patients to access medications either at retail pharmacies or through partnered pharmacies, streamlining the trial process for end-users. The Closed Network Pharmacies enable direct product shipping to patients across all 50 states, ensuring efficient access to medications.

Additionally, their Returns Management Services facilitate the entire returns process, including authorization requests and credit issuance, enhancing operational efficiency for client companies. eStrat's target clientele includes pharmaceutical manufacturers, pharmacies, and healthcare providers, serving a diverse range of end-users in the healthcare sector across the United States. eStrat generates revenue through a structured transaction model involving partnerships with pharmaceutical manufacturers and pharmacies. Their Co-Pay Assistance Programs and Returns Management Services are typically engaged under B2B arrangements, where pharmaceutical companies pay for the management of their co-pay services and returns processing.

Through these partnerships, eStrat may establish pricing structures based on service packages tailored to client needs, which could include fixed fees or performance-based incentives linked to service outcomes. The revenues are also bolstered by the efficiency of their Closed Network Pharmacies, where product distribution is optimized, providing additional value to both manufacturers and patients. Furthermore, the company's innovative approach to managing returns and co-pay transactions positions it as a significant partner for pharmaceutical companies looking to enhance their operational efficiency and reduce costs associated with product returns. The acquisition of eStrat by Apollo Care in January 2026 allows for the expansion of its co-pay platform.

Future growth strategies include the launch of new products aimed at enhancing service delivery and expanding into new geographic regions, specifically targeting opportunities within the broader North American market. The recent acquisition funding will support these initiatives, enabling eStrat to enhance its existing services and explore new market segments.